{{Rsnum
|rsid=3766404
|Gene=CFH
|Chromosome=1
|position=196682702
|Orientation=plus
|GMAF=0.1887
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=CFH
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 3.6 | 22.3 | 74.1
| HCB | 0.0 | 17.4 | 82.6
| JPT | 0.0 | 16.2 | 83.8
| YRI | 27.0 | 55.3 | 17.7
| ASW | 12.3 | 52.6 | 35.1
| CHB | 0.0 | 17.4 | 82.6
| CHD | 0.9 | 16.7 | 82.4
| GIH | 11.0 | 39.0 | 50.0
| LWK | 14.2 | 39.6 | 46.2
| MEX | 0.0 | 16.1 | 83.9
| MKK | 3.9 | 40.9 | 55.2
| TSI | 1.0 | 29.7 | 69.3
| HapMapRevision=28
}}[[age related macular degeneration]] {{PMID|15870199|OA=1
}}

{{PMID|18043728|OA=1
}} Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration.

{{PMID|20378180|OA=1
}} Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy.

{{PMID Auto
|PMID=23582991
|Title=Genetic Influences on the Outcome of Anti-Vascular Endothelial Growth Factor Treatment in Neovascular Age-related Macular Degeneration
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}